Keyphrases
Short-chain Fatty Acids
100%
Targeted Proteomics
100%
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Healthy Controls
37%
Fibrosis
25%
Liver Fibrosis
25%
Fatty Acid Composition
25%
Gut Microbiota
25%
Propionate
25%
Significant Fibrosis
25%
Valerate
25%
Blood Samples
12%
Plasma Concentration
12%
Between-group Difference
12%
Logistic Regression
12%
Disease Control
12%
Gas Chromatography-tandem Mass Spectrometry (GC-MS/MS)
12%
Linear Regression
12%
Venous Blood
12%
Butyrate
12%
Formate
12%
Acetate Concentration
12%
Immunology and Microbiology
Blood Plasma
100%
Intestine Flora
66%
Tandem Mass Spectrometry
66%
Blood Level
33%
Metabolic Regulation
33%
Venous Blood
33%
Gas Chromatography
33%
Gas Chromatography Mass Spectrometry
33%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Disease
100%
Short Chain Fatty Acid
100%
Fibrosis
50%
Intestine Flora
25%
Liver Fibrosis
25%
Propionic Acid
25%
Valerate
25%
Butyrate
12%
Formate
12%